Byotrol Share Discussion Threads

[mudbath] 08/7/2016 18:10

I never give up tonsil.

Way to go, but my 10 pence initial target does not look so distant any more.

[tonsil] 08/7/2016 11:28

Mud bathWhere are you? It's your birthday. If you gave up you called the bottom.

[emeraldzebra] 08/7/2016 10:03

tonsil: i would disagree. i am sure your timing will prove itself to immaculate.

[tonsil] 08/7/2016 09:34

Must be a mug. Just had another punt on this lamest of ducks. 750000 shares bought this morning in total.

[apfindley] 08/7/2016 09:30

Looking good.Take a punt on GWMO too could multibag very soon.

[tonsil] 08/7/2016 09:18

TRADING UPDATENOTICE OF PRELIMINARY RESULTSExtension of Agreement with SolvayByotrol plc, the specialist anti-microbial technology company, is pleased to announce a further and expanded agreement (the "Agreement") to develop and commercialise long-lasting biocidal products for hard surfaces with the international chemical group Solvay SA ("Solvay").The Agreement extends the commercial and technical relationship between the Company and Solvay's Novecare global business unit, a world leader in specialty polymers and surfactants with an annual turnover in excess of EUR2.0 billion. Whereas the initial agreement, announced in June 2015, was primarily targeted at the EU consumer market, this Agreement anticipates an expanded list of countries and markets. Under the terms of the Agreement, Novecare will make a substantial cash payment to the Company in the current financial year.Further commercial deals and results of testingWe updated the market in February on the progress of several new deals and are now pleased to report further commercial progress on almost all fronts, including:-- A 5-year exclusive license on hand sanitising products with the Japanese pharmaceutical company KYORIN Pharmaceutical Co., Ltd, the core subsidiary of the Japanese healthcare group KYORIN, which reports annual sales in excess of Yen100bn. This agreement is aimed at product launches in the Japanese professional medical care market in late 2016 with the consumer market to follow thereafter.-- A 5-year license over Byotrol's new surface care formulations with the European pet care company Beaphar, with products planned for imminent launch in continental Europe (as national product registrations are received).-- A short development contract in long-lasting hand sanitisers with Rentokil Initial plc to support their Ultraprotect range of products in (mostly) European countries, which, assuming successful test results, will then become a 3-year license agreement. This is a newly-developed formulation that, unlike first-generation Byotrol hand products, will meet the new and stringent standards of the European Biocides Regulations.-- Our surface care formulations in the US continue to make excellent progress in the technical tests required for formal EPA approval. We now expect to file the completed regulatory technical dossier in October this year. This formulation sits outside our agreement with Solvay and is already generating considerable commercial interest in the US.In addition:-- Joint testing of our surface care formulations in the NHS has been completed. Results are positive but the Board believes there is still insufficient depth of data to secure sizeable contracts. The Board is now considering how best to proceed.-- In June 2015 the Company secured a GBP100k grant to investigate the biocidal properties of seaweed. Testing continues and whilst it is early in the process, initial data is encouragingTrading UpdateResults for the year to 31 March 2016 are expected to be released in late August. The Board is still expecting to report results in line with the Trading Update released on 25 February, 2016. On an unaudited basis we are expecting to report: -- EBITDA loss before exceptionals of GBP449k versus GBP526k the previous year -- Sharply narrowed loss after tax of GBP532k (after all exceptionals and tax credits) versus a loss of GBP749k the previous year -- Cash and cash equivalents of over GBP1mn, compared to GBP287k in the prior year The results will also show:-- The impact of moves to re-focus the business into higher margin markets, including by way of development agreements, alliances and licenses. As a result, turnover is expected to be approximately GBP2.65m versus GBP3.25m in the prior year, with gross margin increasing significantly to 44% versus 35% in the prior year.-- Continued good management of costs, with operating costs likely to be flat with the prior year at GBP1.6m-- Current year exceptional costs for a quality issue in the supply chain of our wipes business, which we currently estimate at less than GBP50k (net). The issue is now completely addressed without any impact on our long-term customer or supplier relationships.With the various improvements in the business and the recent cash-generating contracts, the Directors believe that the Company has sufficient working capital to drive the business forward.

[mudbath] 04/7/2016 20:50

That was the third "final round" in the past 18 months maxk.

"£14250 quids worth, not a lot..."
Quite a lot though,if you happened to have paid £50k for them.

[maxk] 04/7/2016 20:08

Looking back at the various rns releases, found this:


"Elsewhere, our final round of testing with ISS for Byotrol efficacy in hospital wards is due to start at the end of February, with results expected in April."



What happened?

[maxk] 04/7/2016 20:03

£14250 quids worth, not a lot versus market cap.

Cheesed off punter? (no shortage I suspect)

[mudbath] 04/7/2016 19:20

I wonder who dumped half a million BYOT shares at 2.85 pence just before the close today(and whether they know something we do not).
The US$ aspect of those "accelerated EPA costs"cannot be much fun.
Now where are those preliminary results ?

[brownson] 24/6/2016 10:59

Spoke too soon

[brownson] 24/6/2016 10:19

A safe share amidst the market turmoil. Quality will always out

[brownson] 21/6/2016 16:23

results must be due.

[mudbath] 16/6/2016 08:58

If you mean the remain campaign of fear,brownson,then I could not agree more.
Imo,the votes of the working class and of the more aged wedge of our population will secure our exit.
It would need more than the voices of "vested interests and politicians with aspirations to work for the EU",to persuade me,as a fully paid up member of both the above classifications to ever consider remain as an option.

Byotrol meanwhile has undoubtedly got a wobble on.

[brownson] 15/6/2016 19:15

Skids well and truly under it now. Oh dear oh dear

[brownson] 27/5/2016 17:09

Sadly, I agree. One chance in a lifetime to unshackle but too many vested interests and politicians with aspirations to work for the EU.

[emeraldzebra] 27/5/2016 15:35

there are way too many headless chickens running round for brexit. stay will win by a country mile.

[brownson] 24/5/2016 15:07

Considering we are to expect infection and plague if we leave the EU, all Byotrol shareholders should surely vote for Brexit. A no-brainer methinks

[a.fewbob] 13/5/2016 19:17

smells of a management buyout, run the company into the ground then pick up the assets for next to nothing.

[maxk] 26/4/2016 21:36

This crew couldn't sell water in the Sahara.

[mudbath] 18/4/2016 16:34

It is a pity that Byotrol are no longer keeping shareholders fully updated.

A total void on the blog for 7 months,no announcement regarding their relocation to the Thornton Science Park(which I mentioned last October)and despite a trading update nothing on the status of Byotrol's contract with M&S.

The prelims spelled out the clear and imminent dangers facing the company;including,
"We are a small company. There are several aspects to this but I will touch on two important areas. Firstly, the costs of the senior management team and AIM listing are borne by a small sales figure, inevitably reducing our profitability. Secondly, small upsets can have a disproportionate effect.

It looks to me as though the BOD have their fingers crossed(behind their backs)for salvation of some sort from somewhere.

In the circumstances,it is difficult to remain positive.
All imo.

[wisecat2] 18/3/2016 11:02

strange you can't buy much on the offer

[mudbath] 18/3/2016 10:45

Make your mind up brownson,whether Byotol is half way up or half way down !

"Soon be plenty available below 3p"

One third of the way up for me, as a take out @ 10 pence looks a shoe in.
imo.

[brownson] 17/3/2016 13:43

About due for a tick up I should think